Europe’s Covid-19 cases double in five weeks, total infections surpass 10 million
Europe’s new Covid-19 cases doubled in five weeks, propelling the region across the bleak milestone of 10 million total infections, according to a Reuters tally.
This author has not written his bio yet.
But we are proud to say that Andrew Humphreys contributed 3897 entries already.
Europe’s new Covid-19 cases doubled in five weeks, propelling the region across the bleak milestone of 10 million total infections, according to a Reuters tally.
(Reuters) – AstraZeneca Plc said on Sunday Britain’s health regulator had started an accelerated review of its potential coronavirus vaccine. “We confirm the MHRA’s (Medicines and Healthcare Products Regulatory Agency) […]
Novo Nordisk ended development of the anti-IL-21 antibody NN9828 in combination with Victoza after analyzing Phase II clinical trial data in patients with Type 1 diabetes.
The wind howls and new-fallen leaves swirl around. There’s a sense of dread hanging in the air. Monsters are about, spreading terror across the land. The sound of coughing and gasping breath is coming up fast. A slow look over your shoulder reveals the sweaty, nightmare visage of Covid-19 – or does it?
The United States set a new all-time high for coronavirus cases confirmed in a single 24-hour period, reporting just over 100,000 new infections to surpass the record total of 91,000 posted a day earlier, according to a Reuters tally.
Langland announced the appointment of Angela Rochelle as Account Director, Head of Diversity Initiatives in Clinical Trials.
Johnson & Johnson plans to start testing the company’s experimental Covid-19 vaccine in youths aged 12 to 18 as soon as possible, a company executive said at a meeting held by the U.S. Centers for Disease Control and Prevention (CDC).
U.S. coronavirus cases crossed the 9 million mark, rising by 1 million in two weeks as the world’s worst-affected country faces a resurgence in the pandemic just ahead of elections.
AbCellera and Kodiak Sciences announced a new partnership to create and develop therapeutic antibodies for ophthalmologic indications.
Shares of Bellicum Pharmaceuticals plunged following an announcement that the company will slash 79% of employees as part of a restructuring following the developmental pause for one CAR-T program.